Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

52.91 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32018 Q22018 Q1
Operating Activities:
Net Income -23.42-33.29-35.731-41.902-39.148-31.424-23.419-13.599-22.511-5.743-20.238-14.851-15.6976.34510.376-11.467-10.137-3.25-1.957-1.412-0.682-0.33-0.33
Depreciation & Amortization 0.2840.2390.270.3470.2440.1820.1040.0980.0940.0920.0410.040.0830.1250.0640.040.0240.0170.0150.0190.00900
Deferred Income Tax 0001.456-0.339-1.1170-0.0050000.3580.350.9030.0350.015-0.001000.3040.027-0.034-0.034
Stock Based Compensation 7.4157.4815.5195.4825.255.1923.9063.6713.5833.5322.6742.1792.1192.7941.3630.4380.2240.1730.0040.0050.0040.0020.002
Change In Working Capital -1.66310.252-8.589-2.8071.4053.115-1.4070.0850.044-2.7111.6310.03720.16610.34-29.1710.9050.1460.477-0.070.2050.040.0340.034
Accounts Receivables 0.5880.521-13.647-11.343-5.3622.5-2.50.0340-0.285-0.0172005-250.0160000000
Change In Inventory -0.652-0.692-0.929-3.092-0.01500000.2850-200-184.668-190.5670.1540000000
Change In Accounts Payables 5.8687.08712.3358.0635.8140.409-1.046-0.3661.322-2.1041.9690.357-1.099-0.4415.0630.2151.0721.640.313-0.011-0.0050.0330.033
Other Working Capital -7.4673.336-6.3483.5650.9680.2063.5460.417-1.278-0.607-0.321-0.3221.265190.449181.3330.52-0.926-1.163-0.3830.2160.045-0.033-0.033
Other Non Cash Items 8.7320.9149.042-1.9110.2260.226-1.154-1.1240.2110.5710.6060.1160.0910.0445.5390.0563.1720.0260.0120.0730.0320.0320.032
Operating Cash Flow -8.652-14.404-37.789-39.335-32.362-23.826-21.97-10.874-18.611-4.259-15.286-12.1217.11220.551-11.794-10.013-6.572-2.557-1.996-0.806-0.57-0.296-0.296
Investing Activities:
Investments In Property Plant And Equipment -0.282-1.039-0.1744-4.375-0.787-0.34-0.127-0.096-0.122-0.161-0.274-0.121-0.016-0.175-0.321-0.135-0.335-0.036-0.024-0.006-0.002-0.002
Acquisitions Net 0007.63440-11.6340000000000000000
Purchases Of Investments -24.085-47.026-104.5500.0030-28.667-92.407-57.03100000000000000
Sales Maturities Of Investments 24.49510.542.517.8551.7464.87940.3010.005000000000000000
Other Investing Activites 3-3-102.05-11.634-464.87911.6345.31-57.031000.2740000.371000000.0020.002
Investing Cash Flow 3.128-40.525-102.22417.8547.36864.09211.294-87.219-57.127-0.122-0.161-0.274-0.121-0.016-0.1750.05-0.135-0.335-0.036-0.024-0.006-0.002-0.002
Financing Activities:
Debt Repayment 0750050500020000000000.9890.500
Common Stock Issued -0.043-9.639107.96919.22299.3770.510.0130.292-0.13674.5705.494005.49491.6730000000
Common Stock Repurchased 0-6.685000000-0.1360000000.0280-0.001-0.0270000
Dividends Paid 00000000000000000000000
Other Financing Activities 0.682-23.0420.8020.53899.8930.510.0130.2640.08274.734-0.875-0.0740.0750.0010.01991.51939.9010.133-0.027114.912000
Financing Cash Flow 0.63942.319108.77119.76104.8930.515.0130.264-0.13674.73419.125-0.0740.0750.0010.01991.76339.9010.134-0.02758.4450.500
Other Information:
Effect Of Forex Changes On Cash 000119.947-119.94700000012.12100000000000
Net Change In Cash -4.885-12.61-31.242-1.725119.89940.776-5.663-97.829-75.87470.3533.678-12.4697.06620.536-11.9581.833.194-2.758-2.05957.615-0.0760.5940.594
Cash At End Of Period 176.21181.095193.705224.947226.672106.77365.99771.66169.489245.363175.01171.332183.801176.735156.199168.14986.34953.15555.91357.9720.3570.5940.594